Quotient Sciences Quotient Sciences

X

Digital content for Aucta Pharmaceuticals

  • Webinars & Exhibitions

PharmaCompass

https://www.prnewswire.com/news-releases/aucta-pharmaceuticals-inc-aucta-pharmaceuticals-launches-motpoly-xr-lacosamide-extended-release-capsules-c-v-the-first-and-only-once-daily-formulation-of-lacosamide-302070783.html

PR NEWSWIRE
26 Feb 2024

https://www.prnewswire.com/news-releases/aucta-announced-fda-approval-of-a-generic-version-of-trileptaloxcarbazepine-oral-suspension-301694327.html#:~:text=PISCATAWAY%2C%20N.J.%2C%20Dec.,this%20product%20in%20early%202023.

PR NEWSWIRE
05 Dec 2022

https://www.prnewswire.com/news-releases/aucta-announces-fda-approval-of-a-generic-version-of-perforomist-formoterol-fumarate-inhalation-solution-301691187.html

PRNEWSWIRE
01 Dec 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215332

FDA
30 Nov 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216486

FDA
25 Nov 2022

https://www.prnewswire.com/news-releases/aucta-pharma-and-oakrum-pharma-announce-launch-of-generic-version-of-jadenur-sprinkle-deferasirox-granules-301310888.html

PRNEWSWIRE
14 Jun 2021

https://www.prnewswire.com/news-releases/oakrum-pharma-and-aucta-pharma-announce-us-fda-approval-of-generic-version-of-jadenu-sprinkle-deferasirox-granules-301252585.html

PRNEWSWIRE
22 Mar 2021

https://www.biospace.com/article/fda-action-alert-eton-pharmaceuticals-and-vertex-pharmaceuticals/

Mark Terry BIOSPACE
20 Mar 2020

https://www.ptcommunity.com/wire/oakrum-pharma-announces-launch-pyrimethamine-25mg-tablets-united-states

PTCOMMUNITY
12 Mar 2020

https://www.nasdaq.com/articles/fda-says-no-to-epilepsy-drug-imv-advances-covid-19-vaccine-isee-delays-study-2020-03-19

NASDAQ
11 Mar 2020
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY